Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Progyny, Inc. (PGNY : NSDQ)
 
 • Company Description   
Progyny Inc. is a fertility benefits management company. It specializes in fertility and family building benefits solutions. Progyny Inc. is based in New York, United States.

Number of Employees: 265

 
 • Price / Volume Information   
Yesterday's Closing Price: $32.08 Daily Weekly Monthly
20 Day Moving Average: 662,970 shares
Shares Outstanding: 91.94 (millions)
Market Capitalization: $2,949.57 (millions)
Beta: 2.01
52 Week High: $68.32
52 Week Low: $31.57
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -18.66% -14.47%
12 Week -27.96% -20.58%
Year To Date -36.29% -23.68%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1359 BROADWAY
-
NEW YORK,NY 10018
USA
ph: 212-888-3124
fax: -
investors@progyny.com http://www.progyny.com
 
 • General Corporate Information   
Officers
Peter Anevski - Chief Executive Officer and Director
David Schlanger - Executive Chairman
Mark Livingston - Chief Financial Officer
Beth Seidenberg - Director
Malissia Clinton - Director

Peer Information
Progyny, Inc. (CHCR)
Progyny, Inc. (ESRX)
Progyny, Inc. (MYDP)
Progyny, Inc. (GBCS)
Progyny, Inc. (LAXAF)
Progyny, Inc. (IPCM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 74340E103
SIC: 8090
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/04/22
Share - Related Items
Shares Outstanding: 91.94
Most Recent Split Date: (:1)
Beta: 2.01
Market Capitalization: $2,949.57 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.05 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.09 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 21.06% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 343.71
Trailing 12 Months: 57.29
PEG Ratio: 16.32
Price Ratios
Price/Book: 10.52
Price/Cash Flow: 43.25
Price / Sales: 5.36
EPS Growth
vs. Year Ago Period: -66.67%
vs. Previous Quarter: -66.67%
Sales Growth
vs. Year Ago Period: 41.01%
vs. Previous Quarter: 35.02%
ROE
03/31/22 - 23.15
12/31/21 - 30.41
09/30/21 - 29.67
ROA
03/31/22 - 15.63
12/31/21 - 20.22
09/30/21 - 19.34
Current Ratio
03/31/22 - 2.40
12/31/21 - 2.62
09/30/21 - 2.44
Quick Ratio
03/31/22 - 2.40
12/31/21 - 2.62
09/30/21 - 2.44
Operating Margin
03/31/22 - 10.09
12/31/21 - 13.14
09/30/21 - 12.23
Net Margin
03/31/22 - 10.09
12/31/21 - 13.14
09/30/21 - 18.96
Pre-Tax Margin
03/31/22 - 3.72
12/31/21 - 6.48
09/30/21 - 7.18
Book Value
03/31/22 - 3.04
12/31/21 - 2.78
09/30/21 - 2.51
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©